PURE Bioscience (OTCMKTS:PURE) Posts Earnings Results

PURE Bioscience (OTCMKTS:PURE) released its quarterly earnings results on Monday. The company reported ($0.01) earnings per share for the quarter, Zacks reports.

PURE Bioscience Trading Down 9.6 %

OTCMKTS:PURE traded down $0.01 during trading hours on Monday, reaching $0.06. 15,612 shares of the company traded hands, compared to its average volume of 29,614. The business’s 50-day moving average price is $0.09 and its two-hundred day moving average price is $0.08. PURE Bioscience has a 1 year low of $0.06 and a 1 year high of $0.16. The stock has a market capitalization of $7.08 million, a P/E ratio of -1.75 and a beta of 0.01.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.